You are here

Interventional Cardiology

We’re at the forefront of clinical and technical advancements. Our skilled and dedicated physicians have established clinical programs and conducted research that have kept the University of Minnesota at the forefront of clinical and technical advancements in interventional cardiology for decades, benefiting many patients in Minnesota and beyond.

In the first eight months of the program, 20 patients have successfully received this therapy, giving them a chance at a new life.

In September 2010, a randomized multicenter trial evaluated treatment methods for patients with inoperable aortic stenosis. The trial compared standard medical therapy to Transcatheter Aortic Valve Implantation (TAVI). The results demonstrated a 46 percent reduction in all-cause mortality and a 61 percent reduction in cardiovascular mortality at 24 months with treatment by TAVR. Based on these findings, the FDA approved the Edwards-Sapien TAVI in patients with inoperable aortic stenosis.

Shortly following the release of the Edwards-Sapien TAVI, we put together a TAVR team to provide this groundbreaking treatment. Our team consists of interventional cardiologists, echocardiographers, CT cardiologists, CV surgeons, vascular surgeons, anesthesia team, and core staff from the cardiac catheterization laboratory and operating room.

Contact us

For Patients

This website provides information about the faculty, educational programs, and academic activities at the University of Minnesota Cardiovascular Division. This site contains academic program information only.